• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconEli Lilly

Eli Lilly

Page 7 of 7
Eli Lilly & Co Chief Executive Officer John Lechleiter Interview
Health
Eli Lilly’s CEO John Lechleiter Is Retiring at the End of the Year
By ReutersJuly 27, 2016
Johns Hopkins Hospital Continues Cancer Research And Treatment
Health
These Are the Most Promising Experimental Cancer Drugs
By Sy MukherjeeJune 9, 2016
General Views of Eli Lilly & Co.
Health
Pharma Giant Eli Lilly Wants to Launch 20 New Drugs by 2023
By Sy MukherjeeMay 24, 2016
The CEO of Valeant Pharmaceuticals has suggested that Allergan is fat, overstaffed and ripe for big
Health
Allergan Struck a $3.3 Billion Alzheimer’s Drug Deal Right After Its Pfizer Merger Collapsed
By Sy MukherjeeApril 7, 2016
U.S. Multinationals in Puerto Rico
Health
Eli Lilly Just Lost the Latest Round in its Patent Battle
By ReutersFebruary 12, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance
Biotech Stocks Crashed and Nobody Knows Why
By Jen WiecznerJanuary 28, 2016
U.S. Multinationals in Puerto Rico
Finance
Eli Lilly’s Outlook for 2016 Disappoints
By ReutersJanuary 5, 2016
CHINA-ECONOMY-STOCKS
Retail
China Stocks and December Auto Sales–5 Things to Know Today
By Laura LorenzettiJanuary 5, 2016
Prediction: A New Drug Will Soon Offer Hope in the Alzheimer’s Fight
Health
Prediction: A New Drug Will Soon Offer Hope in the Alzheimer’s Fight
By Erika FryDecember 1, 2015
U.S. Multinationals in Puerto Rico
Health
FDA Approves New Eli Lilly Drug for Advanced Lung Cancer
By Laura LorenzettiNovember 24, 2015
Eli Lilly & Co's Zyprexa schizophrenia drug is pictured in a
Finance
Eli Lilly adds one more to roster of failed heart drugs, and it won’t be the last
By Laura LorenzettiOctober 12, 2015
General Views of Eli Lilly & Co.
Health
Why drug maker Eli Lilly’s stock price is down big today
By John KellOctober 12, 2015
Apple Worldwide Developers Conference Opens In San Francisco
Features
Apple, Greek banks, and earnings — 5 things to know this week
By Tom Huddleston Jr.July 19, 2015
1...
  • 3
  • 4
  • 5
  • 6
  • 7
7
Most Popular
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Personal Finance
Current price of oil as of July 1, 2026placeholder alt text
By Joseph HostetlerJuly 1, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.